Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2012) 120 (21): 357.

https://doi.org/10.1182/blood.V120.21.357.357

Published: 2012

Journal Articles

Prognostic Effect of ASXL1 Mutations in Patients with MDS and Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Christian Koenecke, MD, Felicitas Thol, MD, Patrick Löffeld, Stefanie Buchholz, MD, Michael Stadler, MD, Gudrun Göhring, MD, Elke Dammann, Moritz Kleine, MD, Wiebke Brauns, Michael Hallensleben, MD, Jörg Schmidtke, MD, Brigitte Schlegelberger, M.D., Jürgen Krauter, Arnold Ganser, MD, Michael Heuser, M.D.

Blood (2011) 118 (21): 1709.

https://doi.org/10.1182/blood.V118.21.1709.1709

Published: 2011

Journal Articles

Persistence of Recipient-Derived Antiviral T cells Severely Influence Donor Chimerism Post Allogeneic HSCT,

Sylvia Borchers, PhD, Michael Stadler, MD, Susanne Luther, Tina Ganzenmueller, Brigitte Pabst, Stefanie Buchholz, MD, Elke Dammann, Arnold Ganser, MD, Eva M Weissinger, MD

Blood (2011) 118 (21): 3240.

https://doi.org/10.1182/blood.V118.21.3240.3240

Published: 2011

Journal Articles

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Eva M. Weissinger, MD, Daniel Wolff, Jochen Metzger, Christiane E Dobbelstein, MD, Stefanie Buchholz, MD, Elke Dammann, Uwe Borchert, Annika Krons, Helmut Diedrich, Michael Stadler, MD, Anne M Dickinson, PhD, Ernst Holler, M.D., Hildegard T. Greinix, MD, Juergen Krauter, MD, Arnold Ganser, MD

Blood (2011) 118 (21): 1970.

https://doi.org/10.1182/blood.V118.21.1970.1970

Published: 2011

Journal Articles

Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS,

Christiane E Dobbelstein, MD, Jochen Metzger, Elke Dammann, Uwe Borchert, Stefanie Buchholz, MD, Michael Stadler, MD, Matthias Eder, MD, Juergen Krauter, MD, Arnold Ganser, MD, Eva Mischak-Weissinger, MD

Blood (2011) 118 (21): 4128.

https://doi.org/10.1182/blood.V118.21.4128.4128

Published: 2011

Journal Articles

Matched Pair Analysis of Cryopreserved Versus Fresh Allogeneic Peripheral Blood Stem Cell Transplantation

Arne Trummer, MD, Juergen Krauter, MD, Michael Stadler, MD, Arnold Ganser, MD, Stefanie Buchholz, MD

Blood (2011) 118 (21): 4529.

https://doi.org/10.1182/blood.V118.21.4529.4529

Published: 2011

Journal Articles

Prospective Evaluation of An Agvhd-Specific Proteomic Pattern in More Than 340 Patients.

Eva M. Mischak-Weissinger, MD, Ernst Holler, PhD, Michael Schleuning, Gernot Beutel, Dr., Hildegard Greinix, Anne M Dickinson, PhD, James LM Ferrara, MD, Stefanie Buchholz, MD, Annika Krons, Julia Kontsendorn, Norbert Hahn, Axel R. Zander, Hans-Jochem Kolb, Jochen Metzger, PhD, Arnold Ganser, MD

Blood (2009) 114 (22): 347.

https://doi.org/10.1182/blood.V114.22.347.347

Published: 2009

Journal Articles

Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients.

Michael Stadler, MD, Elke Dammann, Stefanie Buchholz, MD, Bernd Hertenstein, MD, Juergen Krauter, MD, Matthias Eder, MD, Arnold Ganser, MD

Blood (2009) 114 (22): 3388.

https://doi.org/10.1182/blood.V114.22.3388.3388

Published: 2009

Journal Articles

Tissue-Factor- and PSGL-1-Bearing Microparticles Are Strong Outcome Predictors in Allogeneic Stem Cell Transplantation.

Arne Trummer, MD, Christiane De Rop, MD, Michael Stadler, MD, Stefanie Buchholz, MD, Arnold Ganser, MD

Blood (2009) 114 (22): 2263.

https://doi.org/10.1182/blood.V114.22.2263.2263

Published: 2009

Journal Articles

Circulating Angiopoietin-2 Predicts Time to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Christian Koenecke, MD, Philipp Kümpers, MD, Alexander Lukasz, Hartmut Hecker, MD, Elke Dammann, Willem Verhagen, MD, Sascha David, MD, Gudrun Göhring, MD, Stefanie Buchholz, MD, Eva Weissinger, MD, PhD, Jürgen Krauter, MD, Ph.D., Matthias Eder, MD, Ph.D., Hermann Haller, MD, Ph.D., Arnold Ganser, MD, PhD

Blood (2008) 112 (11): 3259.

https://doi.org/10.1182/blood.V112.11.3259.3259

Published: 2008

Journal Articles

Extramedullary Acute Leukemias prior to and after Allogeneic Hematopoietic Stem Cell Transplantation: a Single Center Study.

Michael Stadler, MD, PhD, Helmut Diedrich, MD, Elke Dammann, Stefanie Buchholz, MD, Eva Mischak-Weissinger, MD, PhD, Juergen Krauter, MD, PhD, Matthias Eder, MD, PhD, Arnold Ganser, MD, PhD

Blood (2008) 112 (11): 3262.

https://doi.org/10.1182/blood.V112.11.3262.3262

Published: 2008

Journal Articles

FLAMSA Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in High Risk Myeloid Malignancies Is Also Feasible with Partially Mismatched Donors.

Michael Stadler, MD, Elke Dammann, Stefanie Buchholz, MD, Bernd Hertenstein, MD, Juergen Krauter, MD, Matthias Eder, MD, Arnold Ganser, MD

Blood (2007) 110 (11): 3068.

https://doi.org/10.1182/blood.V110.11.3068.3068

Published: 2007

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients - A Single Center Study.

Michael Stadler, MD, PhD, Bernd Hertenstein, MD, PhD, Juergen Krauter, MD, PhD, Stefanie Buchholz, MD, Elke Dammann, Matthias Eder, MD, PhD, Arnold Ganser, MD, PhD

Blood (2006) 108 (11): 3030.

https://doi.org/10.1182/blood.V108.11.3030.3030

Published: 2006

Journal Articles

Hemostatic Alterations in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Stefanie Buchholz, MD, Alexander Woywodt, MD, Johanna Scheer, Lothar Hambach, MD, Haytham Kamal, Hermann Haller, MD, Marion Haubitz, MD, Arnold Ganser, MD, Bernd Hertenstein, MD, Mario von Depka, MD

Blood (2004) 104 (11): 985.

https://doi.org/10.1182/blood.V104.11.985.985

Published: 2004

NARROW

Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Effect of ASXL1 Mutations in Patients with MDS and Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Persistence of Recipient-Derived Antiviral T cells Severely Influence Donor Chimerism Post Allogeneic HSCT,

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation

Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS,

Matched Pair Analysis of Cryopreserved Versus Fresh Allogeneic Peripheral Blood Stem Cell Transplantation

Prospective Evaluation of An Agvhd-Specific Proteomic Pattern in More Than 340 Patients.

Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients.

Tissue-Factor- and PSGL-1-Bearing Microparticles Are Strong Outcome Predictors in Allogeneic Stem Cell Transplantation.

Circulating Angiopoietin-2 Predicts Time to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Extramedullary Acute Leukemias prior to and after Allogeneic Hematopoietic Stem Cell Transplantation: a Single Center Study.

FLAMSA Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in High Risk Myeloid Malignancies Is Also Feasible with Partially Mismatched Donors.

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients - A Single Center Study.

Hemostatic Alterations in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only